A respiration device (1) supports cardio-pulmonary resuscitation (CPR) and a method for operating a respiration device (1) supports cardio-pulmonary resuscitation (CPR). The respiration device (1) has a control and regulation unit (7) in order to actuate an expiratory metering unit (3), and an inspiratory metering unit (2) such that, in a first phase, a current value of pressure is increased relative to a first pre-defined value (16) and such that, in a second phase, the current value of the pressure is reduced relative to the first pre-defined value (16).

Methods and systems are provided for delivering anesthetic agent to a patient. In one embodiment, an anesthetic vaporizer includes a sump configured to hold a liquid anesthetic agent; an ultrasonic transducer coupled to a bottom of the sump and at least partially disposed within the sump; a vaporizing chamber fluidically coupled to the sump; and a heating element coupled to the vaporizing chamber and configured to increase a temperature of a surface disposed within the vaporizing chamber.

Systems slow breathing with positive pressure therapy. In embodiments, a current interim breathing rate target is set, and periodically magnitude of a variable pressure waveform scaled to the current interim breathing rate target is increased if breathing rate is greater than the interim rate target to lengthen breath duration. The magnitude of the pressure increase may be a function of the difference between the interim rate target and the breathing rate. The interim rate target may be reduced in response to slowing breathing rate. The waveform cycles, inhalation to exhalation, when airflow decreases to a cycle threshold. Different interim rate targets have different cycle threshold functions that allow easier cycling as the interim rate targets decrease. Similarly, the waveform triggers, exhalation to inhalation, when airflow increases to a trigger threshold. Different interim rate targets have different trigger threshold functions that allow easier triggering as the interim rate targets decrease.

A process and a device determine an indicator of an intrinsic end-expiratory pressure in the lungs of a patient. Embodiments are based on the device, ventilator with the device, and the process using the device that includes an interface arrangement configured for an exchange of information with a ventilation device and a control unit that determines first information on a first breathing pressure generated by muscles of the patient, at a first time, at which an inhalation attempt of the patient is present and determines second information on a second breathing pressure generated by the muscles of the patient, at a second time, at which breathing gas flow towards the patient starts. The control unit further determines the indicator of the intrinsic end-expiratory pressure based on the first information and based on the second information.

An electronic vaporizer system includes an anesthetic sump containing anesthetic agent, a vaporizer unit that vaporizes the anesthetic agent from the sump and delivers the vaporized agent to a patient breathing circuit, and a gas sensor configured to measure end tidal concentration of the anesthetic agent and exhalation gasses from the patient. A control system is configured to receive the measured end tidal concentration of anesthetic agent and compare the measured end tidal concentration to a desired end tidal concentration to be maintained for the patient. The vaporizer unit is then automatically controlled to deliver an amount of vaporized agent to the patient based on the comparison.

The present disclosure relates to a method for continuous and noninvasive estimation of mixed venous blood saturation [SvO2] in a mechanically ventilated subject (3). The method comprises the steps of measuring (S1; S10) an expiratory carbon dioxide [CO2] content in expiration gas exhaled by the subject, measuring (S2; S20) an expiratory flow or volume of expiration gas exhaled by the subject, estimating (S3; S30) a cardiac output [CO] or an effective pulmonary blood flow [EPBF] of the subject from the measured expiratory CO2 content and the measured expiratory flow or volume using a capnodynamic Fick method, and estimating (S4; S40) SvO2 based on the estimated CO or the EPBF of the subject.

Methods and systems for assessing characteristics of a lung of a patient. A method includes, during an applied positive end expiratory pressure, identifying a first position of a patient, acquiring first impedance data representative of at least a region of patient's lung when the patient is in the first position, during the applied positive end expiratory pressure, identifying a second different position of a patient, acquiring second impedance data representative of at least the region of patient's lung when the patient is in the second position, comparing the first impedance data with the second impedance data, and determining whether the applied positive end expiratory pressure is sufficient to effectuate recruitment.

In some implementations, a low dead space airway adapter for sampling fluid flowing through a ventilation assembly includes an outer wall configured to couple to an endotracheal (ET) tube adapter and an internal projection positioned at least partially within an internal cavity defined by the outer wall and configured to extend within an internal cavity of the ET tube adapter when the airway adapter is in use. The internal projection can include a fluid passageway configured for fluid communication with at least a portion of the internal cavity of the ET tube adapter and a free end comprising an opening in fluid communication with the fluid passageway. At least a portion of the free end can be chamfered around the opening and configured to contact an inner surface of the ET tube adapter when the outer wall is coupled to the ET tube adapter.

An automatic control system for a manual mechanical ventilation device comprising a servomotor, an actuator and a stepper cylinder adapted to compress the mechanical ventilation device in response to signals sent by a controller. The controller is further connected to at least one flow sensor and one pressure sensor and has a human-machine interface for the insertion of pressure and oxygen flow output values to be received by a patient.

The present invention pertains to a system, method, and device for treating sleep disorders. The present invention is particularly useful in the delivery of carbon dioxide (CO2) to a subject and in the treatment of sleep apnea. Furthermore, integration of components with various sensors and apparatuses associated therewith and attached thereto preferably complete a rebreathing circuit in the present invention. In various embodiments of the present invention where the above components are integrated as a rebreathing circuit, a subject is both the source and recipient of a controlled concentration of carbon dioxide. In such embodiments, treatment of sleep disorders becomes much more efficient and effective.